(Press-News.org) New insights into how a promising HIV vaccine works are provided in a study published by Cell Press January 10th in the journal Immunity. By analyzing the structure of antibody-virus complexes produced in vaccine recipients, the researchers have revealed how the vaccine triggers immune responses that could fight HIV-1 infection. The study could help guide efforts to increase the vaccine's production, which currently is not high enough for clinical use.
"This is the first comprehensive study of the repertoire of antibodies that were induced by an HIV vaccine and were associated with decreased transmission of HIV," says senior study author Barton Haynes of Duke University Medical Center. "Ultimately, the motivation of the study is to understand how that vaccine works in order to develop ways to make it better."
An estimated 34 million people around the world live with HIV, and the development of a safe and effective vaccine is a global priority. In 2009, a vaccine efficacy trial revealed that the RV144 HIV-1 vaccine protected nearly a third of recipients from infection. In a more recent study, Haynes and his collaborators found that vaccine-induced antibodies targeting variable regions 1 and 2 (V1-V2) of the virus are associated with a decreased risk of HIV-1 infection. But until now it has been unclear whether these antibodies are crucial for protection against the virus or how they might fight off infection.
To address these questions, Haynes and his team isolated antibodies from RV144 vaccine recipients and determined the antibodies' crystal structures both alone and in complex with HIV-1. They found that the V2 region, which is targeted by the antibodies and includes amino acid residue 169, exhibits extreme variation in both its amino acid sequence and its structural conformation. Despite this variation in HIV-1, the antibodies can recognize position 169 on the virus and thereby bind to virus-infected immune cells and mark them for destruction.
The discovery of variation in the sequence and structure of HIV-1's V2 region opens up new avenues for designing vaccines capable of providing more protection than the existing RV144 vaccine. "New technology is allowing the dissection of a complex set of vaccine-induced responses such that new vaccines can be designed to hopefully improve on the beachhead that the RV144 trial provided to the HIV-1 vaccine field," Haynes says.
###
Immunity, Liao et al.: "Vaccine Induction of Antibodies Against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2." END
Study provides new clues for designing an effective HIV vaccine
2013-01-10
ELSE PRESS RELEASES FROM THIS DATE:
Study points to a safer, better test for chromosomal defects in the fetus
2013-01-10
A noninvasive, sequencing-based approach for detecting chromosomal abnormalities in the developing fetus is safer and more informative in some cases than traditional methods, according to a study published by Cell Press January 10th in The American Journal of Human Genetics. This method, which analyzes fetal DNA in the mother's blood, could provide women with a cost-effective way to find out whether their unborn baby will have major developmental problems without risking a miscarriage.
"Our study is the first to show that almost all the information that is available from ...
Regulating single protein prompts fibroblasts to become neurons
2013-01-10
Repression of a single protein in ordinary fibroblasts is sufficient to directly convert the cells – abundantly found in connective tissues – into functional neurons. The findings, which could have far-reaching implications for the development of new treatments for neurodegenerative diseases like Huntington's, Parkinson's and Alzheimer's, will be published online in advance of the January 17 issue of the journal Cell.
In recent years, scientists have dramatically advanced the ability to induce pluripotent stem cells to become almost any type of cell, a major step in ...
Next steps in potential stem cell therapy for diabetes
2013-01-10
Type 1 and type 2 diabetes results when beta cells in the pancreas fail to produce enough insulin, the hormone that regulates blood sugar. One approach to treating diabetes is to stimulate regeneration of new beta cells.
There are currently two ways of generating endocrine cells (cell types, such as beta cells, that secrete hormones) from human embryonic stem cells, or hESCs: either generating the cells in vitro in culture or transplanting immature endocrine cell precursors into mice.
Researchers from the University of California, San Diego School of Medicine, collaborating ...
New insights into HIV vaccine will improve drug development
2013-01-10
DURHAM, N.C. – Four years ago, a potential HIV vaccine showed promise against the virus that causes AIDS, but it fell short of providing the broad protection necessary to stem the spread of disease.
Now researchers -- led by Duke Medicine and including team members from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, the U.S. Military HIV Research Program and the Thailand Ministry of Health -- have gained additional insights into the workings of the vaccine that help explain why it benefited a third of recipients and left ...
Cancer scientists determine mechanism of 1 of the most powerful tumor-suppressor proteins, Chd5
2013-01-10
Cold Spring Harbor, NY – A team of cancer researchers at Cold Spring Harbor Laboratory (CSHL) has solved the mystery of how one of the most powerful of the body's natural tumor-suppressing proteins, called Chd5, exerts its beneficial effects.
The findings, published online today in the journal Cell Reports, are important because Chd5 engages processes fundamental to cancer prevention. Conversely, when Chd5 is mutated or missing, an important door is opened to cancer initiation.
"For this reason, figuring out the mechanics of how Chd5 works to prevent cancer can directly ...
Researchers find causality in the eye of the beholder
2013-01-10
We rely on our visual system more heavily than previously thought in determining the causality of events. A team of researchers has shown that, in making judgments about causality, we don't always need to use cognitive reasoning. In some cases, our visual brain—the brain areas that process what the eyes sense—can make these judgments rapidly and automatically.
The study appears in the latest issue of the journal Current Biology.
"Our study reveals that causality can be computed at an early level in the visual system," said Martin Rolfs, who conducted much of the research ...
Study identifies infants at highest risk of death from pertussis
2013-01-10
ARLINGTON, VA, January 10, 2013—A study released today from the upcoming issue of the Journal of the Pediatric Infectious Diseases Society (JPIDS) found that taking early and repeated white blood cell counts (WBC) is critical in determining whether infants have pertussis and which of those children are at highest risk of death from the disease.
In 2010, California reported its highest pertussis rates in 60 years. Murray, et al.'s retrospective study used medical records from five Southern California Pediatric Intensive Care Units between September 2009 and June 2011. ...
Haiti can quell cholera without vaccinating most people, UF researchers estimate
2013-01-10
GAINESVILLE, Fla. --- Cholera could be contained in Haiti by vaccinating less than half the population, University of Florida researchers suggest in a paper to be published Thursday in the journal Scientific Reports.
The work places UF's Emerging Pathogens Institute in the pro-vaccination camp in an ongoing international debate over how best to contain the two-year-old epidemic that has claimed thousands of lives.
The Centers for Disease Control and Prevention has been skeptical about the effectiveness of vaccination against cholera in this setting. It has instead ...
Teenagers with a low muscular strength have a higher risk of dying early form heart disease
2013-01-10
Teenagers with a low muscular strength have a 30% higher risk of committing suicide before the age of 55 years, and a 65% higher risk of developing psychiatric diseases such as depression of schizophrenia. In addition, a low muscular strength during childhood and adolescence is a strong predictor of early death –i.e. before 55 years of age– from cardiovascular disease. A low muscular strength is as powerful a predictor as obesity and high blood pressure.
This was the conclusion drawn in a study recently published in the Medical Journal –a world-leading medical journal– ...
Declining access to electroconvulsive therapy: A clinical choice or an economic one?
2013-01-10
Philadelphia, PA, January 10, 2013 – Horrific images from One Flew Over the Cuckoo's Nest notwithstanding, modern electroconvulsive therapy (ECT) remains one of the safest and most effective antidepressant treatments, particularly for patients who do not tolerate antidepressant medications or depression symptoms that have failed to respond to antidepressant medications.
Since its introduction in the 1930s, ECT has evolved into a more refined, but more expensive and extensively regulated clinical procedure. Each treatment involves the assembly of a multidisciplinary clinical ...